BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.

Andere talen BrightGene Bio-Medical Technology Co., Ltd.

Aandelen

688166

CNE100003PR1

slotkoers Shanghai S.E. Andere beurzen 00:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
34,48 ^CNY	-0,43%		-2,96%	-1,49%

07/05	Chinese aandelen stijgen nu vastgoedmarkt verlichting krijgt; BrightGene springt 7% omhoog	MT
27/04	BrightGene Bio-Medical Technology Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7%	07/05
BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%	07/05
BrightGene Bio-Medical Technology Co., Ltd. announced that it expects to receive CNY 499.999987 million in funding	06/05
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	27/04
Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/04
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/02
BrightGene Bio-Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	07/02
BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.	06/02
Oralead Pharma announced that it has received funding from HighLight Capital, Shenzhen Qianhai BangQin Investment Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd., Shenyang Borui Pharmaceutical Co., Ltd.	29/01
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Chinese Regulator Issues Warning Against BrightGene Bio-Medical Chairman Over Weight Loss Claims	19-10-23
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	17-10-23
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18-08-23
BrightGene Bio-Medical Technology's Unit Gets Hospital's Approval for Diabetes Drug Trial	27-07-23
Chinese Drug Regulator Certifies Two Drugs of BrightGene's Unit	06-07-23
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24-04-23
BrightGene Bio-Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
BrightGene Bio-Medical to Hike Investment in API Production Project to 500 Million Yuan	08-02-23
Xinchuang Biomedical Technology Subsidiary Gets Nod to Hold Anti-Diabetes Drug Trial	30-12-22
BrightGene Bio-Medical Technology Co., Ltd. announced that it has received CNY 226.613082 million in funding from Horizon Asset Management Co. Ltd., Shanghai Leitu Asset Management Co., Ltd. and other investors	21-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BrightGene Bio-Medical Technology Co., Ltd.

Aandelen

688166

CNE100003PR1

Andere talen

Filters